Klein Liviu, Gheorghiade Mihai
Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Med Clin North Am. 2004 Sep;88(5):1209-35. doi: 10.1016/j.mcna.2004.03.002.
Coronary artery disease is a major contributor to the progression of left ventricular systolic dysfunction and heart failure (HF). Recognizing that coronary artery disease is a leading cause of HF in the United States is critical to reducing mortality resulting from this condition. Although some patients may be candidates for mechanical revascularization to improve left ventricular function, all patients are candidates for aggressive secondary prevention strategies. This review discusses the prevalence of coronary artery disease, prognostic significance and pathophysiology, risk factor modifications, pharmacologic treatments, and the role of revascularization.
冠状动脉疾病是导致左心室收缩功能障碍和心力衰竭(HF)进展的主要因素。认识到冠状动脉疾病是美国心力衰竭的主要原因,对于降低由此导致的死亡率至关重要。虽然一些患者可能适合进行机械血运重建以改善左心室功能,但所有患者都适合积极的二级预防策略。本综述讨论了冠状动脉疾病的患病率、预后意义和病理生理学、危险因素的修正、药物治疗以及血运重建的作用。